On Sep 14, 2021 RecoveryOne closed a Series C round and raised $33,000,000 from 7wire Ventures, Cigna Ventures, Cobalt Ventures, Leverage Health, TELUS Ventures, featuring […]
Series D – Calysta
On Sep 9, 2021 Calysta closed a Series D round and raised $39,000,000 from Adesso, Aqua Spark, BP Ventures, WTI International Inc., featuring lead investors […]
Series C – Solugen
On Sep 9, 2021 Solugen closed a Series C round and raised $350,000,000 from Baillie Gifford, BlackRock, Carbon Direct, Fifty Years, GIC, Refactor Capital, Temasek […]
Series G – RareCyte
On Sep 9, 2021 RareCyte closed a Series G round and raised $24,000,000 from 5AM Ventures, Agilent Technologies, Arboretum Ventures, F-Prime Capital, HealthQuest Capital, Logos […]
Series D – Mammoth Biosciences
On Sep 9, 2021 Mammoth Biosciences closed a Series D round and raised $150,000,000 from Decheng Capital, Foresite Capital, Greenspring Associates, Mayfield Fund, NFX, Plum […]
Series G – RareCyte
On Sep 9, 2021 RareCyte closed a Series G round and raised $24,000,000 from 5AM Ventures, Agilent Technologies, Arboretum Ventures, F-Prime Capital, HealthQuest Capital, Logos […]
Series D – INBRACE
On Sep 8, 2021 INBRACE closed a Series D round and raised $102,000,000 from BlackRock, Endeavour Vision, Farallon Capital Management, Marshall Wace, MVM Life Science […]
Series E – Emulate
On Sep 7, 2021 Emulate closed a Series E round and raised $82,000,000 from Northpond Ventures, Perceptive Advisors, featuring lead investors Northpond Ventures. About the […]
Series E – Emulate
On Sep 7, 2021 Emulate closed a Series E round and raised $82,000,000 from Northpond Ventures, Perceptive Advisors, featuring lead investors Northpond Ventures. About the […]
Series D – Owlstone Medical
On Sep 7, 2021 Owlstone Medical closed a Series D round and raised £42,000,000 from Horizons Ventures, featuring lead investors Horizons Ventures. About the company: […]
